Clinical Trial Update: BLYS and IFN in SLE

View source ↗

Summary

A completed clinical trial evaluated belimumab (BLyS inhibitor) in combination with interferon for systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED